RajeshKunadharajuMDFACP
Pulmonology • Stockton, CACritical Care Medicine, Interstitial Lung Diseases, Pulmonary Vascular Medicine
Attending Physician
Dr. Kunadharaju is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1801 E March Ln
Ste C300
Stockton, CA 95210Phone+1 209-464-6422Fax+1 209-464-0193
Summary
- Dr. Rajesh Kunadharaju is a pulmonologist in Stockton, CA and is affiliated with multiple hospitals in the area, including St. Joseph's Medical Center and Dameron Hospital. He received his medical degree from Osmania Medical College NTR UHS and has been in practice 6 years. He specializes in critical care medicine, interstitial lung diseases, and pulmonary vascular medicine. He has more than 10 publications and 500 citings.
Education & Training
University at BuffaloFellowship, Pulmonary Disease and Critical Care Medicine, 2019 - 2022
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2013 - 2016
Osmania Medical College NTR UHSClass of 2011
Certifications & Licensure
CA State Medical License 2022 - 2026
WY State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
Publications & Presentations
PubMed
- 10 citationsGabapentin to treat acute alcohol withdrawal in hospitalized patients: A systematic review and meta-analysis.Anna G Mattle, Patrick McGrath, Austin Sanu, Rajesh Kunadharaju, Brian Kersten
Drug and Alcohol Dependence. 2022-12-01 - 27 citationsClinical Presentation and Outcomes of Myocarditis Post mRNA Vaccination: A Meta-Analysis and Systematic ReviewAbhishek Matta, Rajesh Kunadharaju, Marcus Osman, Christy Jesme, Zachary McMiller
Cureus. 2021-11-03 - 3 citationsPoly Adenosine Diphosphate-Ribose Polymerase (PARP) Inhibitors in Pancreatic Cancer.Tejasvi Sunkara, Sai Samyuktha Bandaru, Rajendra Boyilla, Rajesh Kunadharaju, Prithvi Kukkadapu
Cureus. 2022-02-01
Press Mentions
Trial Aims to Determine if Melatonin Can Treat COVID-19September 16th, 2020
CHEST Challenge 2021February 3rd, 2022
Professional Memberships
- Member
- Member
- Member
- Member
External Links
- Google Scholar https://scholar.google.com/citations?user=j9hqbBUAAAAJ&hl=en
- Googlehttps://medicine.buffalo.edu/175/this-is-what-we-do.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
